These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 6465016)
41. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction. Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590 [TBL] [Abstract][Full Text] [Related]
42. Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone. Mostow ND; Vrobel TR; Noon D; Rakita L Circulation; 1986 Jun; 73(6):1231-8. PubMed ID: 3698254 [TBL] [Abstract][Full Text] [Related]
43. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870 [TBL] [Abstract][Full Text] [Related]
44. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone. Vaitkus PT; Buxton AE; Josephson ME; Marchlinski FE Am J Cardiol; 1990 Sep; 66(7):710-4. PubMed ID: 2399887 [TBL] [Abstract][Full Text] [Related]
45. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation. Lerman BB; Waxman HL; Buxton AE; Josephson ME Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435 [TBL] [Abstract][Full Text] [Related]
46. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing. Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013 [TBL] [Abstract][Full Text] [Related]
48. Transient exacerbation followed by control of ventricular tachycardia with amiodarone. Mostow ND; Vrobel TR; Rakita L Am Heart J; 1986 Jan; 111(1):178-80. PubMed ID: 3946146 [No Abstract] [Full Text] [Related]
49. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588 [TBL] [Abstract][Full Text] [Related]
50. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment. Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883 [TBL] [Abstract][Full Text] [Related]